One accountable party,
owning the whole journey from a single spot buy to local production
We work backward from end-market demand to decide which intermediate to make, produce it through our tiered supplier network, prove it with our quality governance system, and deliver it compliantly via our overseas platform. You can start with a single spot purchase—once trust is established, we can move on to process development and tech transfer.
We don't promise to do 'everything,' nor do we dress up as a full-stack giant. We state our boundaries clearly: where we can deliver, we say to what extent; where we can't, we tell you exactly where to look.
Let's start with the four things you worry about most
In cross-border pharma-intermediate sourcing, the problem was never 'is there stock'—it's these four things.
Dozens of Chinese plants can make this intermediate, with quotes ranging from 800 to 3,000—and no one tells you where the gap is, or in which document.
Who issued the CoA, and was the method validated? Are batch numbers continuous? Will changes be notified? If the plant switches, do we re-run the impurity profile?
Getting the goods is only the start: export docs, registration files, cold-chain and hazardous shipping, target-market compliance—who owns it?
Five suppliers each own one slice; a plant changes staff, a lab drops the ball, lead times slip—and in the end the customer comes to you, yet you control none of it.
We offer three delivery tiers, matched to your stage of need
Not sure which tier to start at? Most clients begin with Trade, using one or two batches to gauge our reliability.
You already know the exact product and need qualified material now
- Match pre-audited suppliers to your spec and produce a tiered quotation
- Place orders against a signed quality agreement, locking batch and lead time
- Deliver full batch documentation with the goods—never just a single CoA
The material isn't in any catalog, or existing suppliers can't hit your spec
- Technical review sets the route and acceptance criteria before any work begins
- Lab trial → analytical method development & validation → impurity profile & forced degradation
- Scale-up and process validation to build a reproducible tech package
You need a second source, local production, or to pass regulatory review
- Transfer the full process and method package, reproduced to acceptance criteria
- Scale-up validation and batch-to-batch continuity confirmation
- Compilation of registration dossiers and lifecycle maintenance support
Why structure it this way? Because trust in a cross-border supply relationship is built layer by layer: first we prove we can deliver a qualified batch on time, then that we can solve a spec no one else has, and only last do we discuss handing over process and registration files. We won't pitch tech transfer on a first engagement, nor force a consulting package when you only want material.
Underpinning these three tiers are three layers of capability
In a seller's market, everyone claims to have a network and resources. We break these three layers out so you can check each one.
We don't start from 'whatever the plant has to sell.' We work back from end-market demand: which blockbusters are near their patent cliff, which generics are being filed intensively, and which critical fragments no one can make.
- LOE opportunity library: an opportunity list organized by patent cliff and critical intermediate
- Each opportunity tags the end drug, window period, critical fragment, technical barrier and supply concentration
- Conclusion before quotation—we explain 'why this one' before we discuss price
Suppliers aren't a price-comparison list—they're a tiered network: core plants for volume, flexible plants for special reactions, analytical labs for cross-checking. Technical barriers live in the process, not in the pitch.
- Core plants (long-term): quality and confidentiality agreements lock in priority capacity
- Flexible plants: small-batch custom, hazardous & highly potent reactions, special equipment
- Technical strengths: chiral synthesis & asymmetric catalysis · fluorinated and difluorinated building blocks · multi-step coupling & heterocycles · continuous flow and AI-assisted route design
This is the line that separates a 'trader' from a 'solutions partner.' QA doesn't just 'collect reports and stamp them'—it owns audits, agreements, deviations and data integrity.
- Supplier audits & quality agreements: tiering, annual re-review, critical-change notification
- Project quality loop: work order → plan → batch record → QC → deviation / CAPA → CoA → archive
- Data integrity: a unified data room retains raw spectra and batch records, supporting later due diligence and review
We do not promise end-to-end GLP safety assessment or formulation-side cGMP manufacturing, nor do we build our own bulk-chemical capacity. What we provide is supply-chain quality traceability and delivery assurance for pharmaceutical intermediates and APIs: supplier audits, quality agreements, batch documentation, deviation closure and data retention. Where responsibility for safety assessment, clinical trials or formulation registration sits elsewhere, we point clearly to qualified partners rather than glossing over it.
How an order runs end to end
From your brief to delivery, there are six fixed stages, each with a clear deliverable.
- 01IntakeDay 0
Product or CAS, spec & purity, quantity, target country, required documents. Captured in a structured brief—no guessing by email.
Output: Structured requirement brief - 02Technical reviewDay 1–3
Route feasibility, supply match and an initial screen of impurity and compliance risk. If we can do it, we say so; if not, we say so directly.
Output: Review conclusion + recommended plan - 03Commercial proposalDay 3–5
Tiered pricing, MOQ, lead time and quality-agreement terms—all upfront, so terms don't shift mid-talk.
Output: Quotation + draft agreement - 04Production & qualityPer cycle
Batch tracking, deviation & CAPA closure, QC result review; cross-checking arranged for critical projects.
Output: Batch document package - 05Documentation & complianceWith shipment
CoA, batch-record summary, SDS, registration support files and an export-compliance screen—delivered together.
Output: Delivery document package - 06Delivery & reorderOngoing
Logistics & customs follow-up, customer feedback archived, supplier scores fed back into the network.
Output: Delivery confirmation + score record
Progress and documents for steps 2–5 are visible on the platform—check anytime, instead of chasing by email.See the systematic delivery chain →
Who delivers on this
Not one person, one email or one WeChat ID—but a group structure with real entities, clear roles and defined boundaries.
Hong Kong and Singapore entities handle cross-border trade, licensing and settlement, connecting APAC, Europe and North America.
The group's holding and industrial-investment arm, consolidating outbound investment and resource allocation.
The mainland operating and import/export entity, the single point connecting global clients and order fulfillment.
Specialized by segment—formulation MAH, API & intermediates, biologics & delivery, pharma materials, green environmental—and more.
How fees work
We don't run a 'margin-only' model, and we don't hide fees inside quotes. Below are the possible charges, combined per the actual project.
| Item | Billing point | Description |
|---|---|---|
| Material supply | Per batch | A supply price that includes quality management and delivery assurance—not a simple buy-low/sell-high margin. |
| Custom development fee (FFS) | At project start | Scoped by route difficulty, step count and analytical effort—we quote hours and timeline before starting. |
| Tech package / process license | Per milestone | Settled as a lump sum or per milestone, arranged alongside the licensing deal. |
| Long-term supply framework | Annual | Unit price + minimum volume + price-adjustment mechanism, in exchange for capacity priority. |
| Tech transfer & audit support | Per service | Method transfer, on-site support, client-audit accompaniment and remediation follow-up. |
| Registration document services | Per project | DMF / CEP module compilation and lifecycle maintenance support. |
Final amounts and combinations follow the project quotation; there are no undisclosed extra charges.See platform membership & billing rules →
Which tier to start at is your call
Tell us the product or CAS, the spec and quantity you need, and the target country—within 3 business days we return a technical-review conclusion and a commercial proposal. No long-term agreement up front, and no need to disclose your project on first contact.
Clear product and spec; I need a quote and lead time
Not in any catalog, or the spec can't be met
Need a second source, localization, or registration files
The cycles, barriers and deliverables on this page are typical ranges; the actual values follow the project's technical-review conclusion and contract. Matters involving registration and compliance are confirmed manually by the target-country authority and the compliance owner.